Pith. sign in

REVIEW 3 major objections 2 minor

LMV-Net jointly models CC and MLO mammography views with explicit longitudinal alignment to improve breast cancer risk prediction.

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

T0 review · grok-4.5

2026-07-14 01:46 UTC pith:A2BTVAJC

load-bearing objection Abstract-only systems paper: joint multi-view + explicit longitudinal alignment is a sensible gap-fill, but outperformance is unverifiable without methods and numbers. the 3 major comments →

arxiv 2607.11343 v1 pith:A2BTVAJC submitted 2026-07-13 cs.CV cs.AI

Longitudinal Multi-View Breast Cancer Risk Prediction

Solveig Thrun , Zijun Sun , Suaiba A. Salahuddin , Kristoffer Wickstr{\o}m , Elisabeth Wetzer , Stine Hansen , Robert Jenssen , Michael Kampffmeyer This is my paper
classification cs.CV cs.AI
keywords breast cancer risk predictionmammographylongitudinal imagingmulti-viewCC MLOdeep learningEMBEDCSAW-CC
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

This paper argues that breast cancer risk prediction from screening mammograms improves when a model jointly analyzes the two standard complementary views (craniocaudal and mediolateral oblique) inside an explicitly time-aligned longitudinal framework. Prior deep learning work either aligned exams over time using only one view, or fused multiple views without explicit temporal alignment, so neither captured the full spatial-temporal information radiologists routinely use. LMV-Net closes that gap. On the public EMBED and CSAW-CC datasets it consistently outperforms existing risk models overall and within breast-density and cancer subgroups. If the claim holds, multi-view longitudinal modeling can tighten risk stratification, support personalized screening intervals, and focus resources on higher-risk patients earlier.

Core claim

LMV-Net, by jointly analyzing anatomically complementary CC and MLO views within an explicitly aligned longitudinal framework, consistently outperforms existing state-of-the-art breast cancer risk prediction methods in overall performance and across breast density and cancer subgroups on the public EMBED and CSAW-CC datasets.

What carries the argument

LMV-Net itself: a network that fuses the two standard mammographic views (CC and MLO) while enforcing explicit temporal alignment of successive exams, so complementary spatial cues and change over time are modeled together rather than separately.

Load-bearing premise

The reported gains truly come from the joint multi-view plus explicit longitudinal design and not from differences in evaluation protocol, data splits, label windows, preprocessing, or hyperparameter budgets relative to the reimplemented baselines.

What would settle it

A controlled re-run of LMV-Net against the same baselines on EMBED and CSAW-CC under identical splits, follow-up windows, preprocessing, and hyperparameter search budgets that erases or reverses the reported performance gap.

Watch this falsifier — get emailed when new claim-graph text bears on it.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 2 minor

Summary. The manuscript proposes LMV-Net, a longitudinal multi-view deep learning model for breast cancer risk prediction from screening mammography. It jointly analyzes anatomically complementary CC and MLO views inside an explicitly aligned longitudinal framework, aiming to exploit complementary spatial-temporal information that prior work either models with single-view explicit alignment or multi-view without explicit longitudinal alignment. The abstract reports evaluation on the public EMBED and CSAW-CC datasets against state-of-the-art risk prediction methods, claiming consistent outperformance overall and across breast density and cancer subgroups, with code released at a public repository.

Significance. If the empirical claims hold under rigorous, comparable evaluation, jointly modeling multi-view anatomy with explicit longitudinal alignment would be a useful incremental contribution to mammography-based risk prediction and could support more personalized screening intervals and earlier identification of high-risk patients. The clinical motivation is coherent, the use of two public datasets is appropriate, and the stated code release is a concrete reproducibility strength. Significance cannot be fully judged from the abstract alone, because quantitative effect sizes, subgroup robustness, and fairness of baseline comparisons are not yet inspectable.

major comments (3)
  1. The central claim of consistent outperformance over SOTA on EMBED and CSAW-CC (overall and in density/cancer subgroups) is not verifiable from the provided material: no metrics, confidence intervals, statistical tests, result tables, or ablation numbers appear in the abstract. For an empirical ML paper this is load-bearing; the claim cannot be accepted or rejected without those results.
  2. The load-bearing premise that gains come from joint multi-view + explicit longitudinal alignment (rather than evaluation-protocol artifacts) cannot be checked. The abstract does not specify train/val/test splits, follow-up windows, label definitions, preprocessing, hyperparameter budgets, or whether prior single-view-aligned and multi-view-unaligned baselines were reimplemented under matched conditions. Without that protocol, the outperformance attribution remains unsubstantiated.
  3. Architectural and training details of LMV-Net (how CC/MLO complementarity is fused, how explicit longitudinal alignment is realized jointly across views, loss design, and training protocol) are absent from the abstract. These are required to assess whether the method is a genuine technical contribution versus a re-packaging of existing components under a new name.
minor comments (2)
  1. The abstract is readable and clinically motivated, but it would benefit from at least one headline quantitative result (e.g., AUC or C-index with CI on each dataset) so readers can gauge effect size before the full paper.
  2. Clarify in the abstract whether 'cancer subgroups' means cancer subtype, stage, or time-to-event strata, to avoid ambiguity for clinical readers.

Circularity Check

0 steps flagged

Abstract-only empirical ML paper: no derivation chain or circular construction visible; outperformance claim is external-benchmark evaluation, not self-definitional.

full rationale

Only the abstract is available. LMV-Net is presented as a supervised deep-learning model for breast cancer risk prediction that jointly uses CC/MLO views with explicit longitudinal alignment, evaluated on public EMBED and CSAW-CC datasets against prior SOTA methods. There are no equations, fitted constants renamed as predictions, uniqueness theorems, or self-citation chains that force the result by construction. The central claim is empirical outperformance (overall and in density/cancer subgroups), which is falsifiable against external public data rather than tautological. Ordinary ML risks (protocol sensitivity, baseline reimplementation fairness, possible leakage) cannot be audited from the abstract alone and do not constitute the enumerated circularity patterns. Per the hard rules for self-contained external-benchmark work with no visible reduction of outputs to inputs, score is 0 and steps remain empty.

Axiom & Free-Parameter Ledger

2 free parameters · 4 axioms · 1 invented entities

Abstract-only audit. The claim rests on standard supervised deep-learning practice plus domain assumptions about mammography, not on free physical constants or invented particles. Free parameters are the usual NN/training knobs (unlisted in the abstract). No formal axioms; main domain assumptions are that CC/MLO are complementary and that explicit longitudinal alignment plus multi-view fusion improves risk labels. LMV-Net is an invented architecture entity without independent evidence beyond the reported benchmarks.

free parameters (2)
  • Network and training hyperparameters (architecture widths, alignment module design, learning rates, loss weights, etc.)
    Any deep risk model depends on many fitted/chosen hyperparameters; none are specified in the abstract, yet they affect reported outperformance.
  • Risk prediction time horizons / label definitions
    Breast cancer risk labels depend on chosen follow-up windows and inclusion rules; these act as free modeling choices that shape metrics and are not stated in the abstract.
axioms (4)
  • domain assumption CC and MLO mammographic views provide complementary spatial information useful for risk prediction when fused.
    Stated as clinical motivation in the abstract; standard radiology practice but still an assumption about what the model can exploit.
  • domain assumption Explicit longitudinal alignment of exams improves risk prediction over multi-view modeling without such alignment (and vice versa for single-view alignment).
    The paper's gap claim and design rest on this; prior work is said to do only one side.
  • domain assumption Public EMBED and CSAW-CC labels and imaging are adequate external benchmarks for comparing risk models.
    Central empirical claim is defined relative to these datasets; their label quality and cohort biases are taken as given.
  • standard math Standard deep learning optimization and evaluation practices yield reliable comparative rankings of risk models.
    Implicit background for any SOTA comparison in the abstract; not a novel formal axiom.
invented entities (1)
  • LMV-Net (longitudinal multi-view risk prediction architecture) no independent evidence
    purpose: Jointly process aligned CC and MLO sequences to produce breast cancer risk scores.
    New model name/architecture introduced in the abstract; independent evidence would be external clinical validation beyond the two reported benchmarks, which is not shown here.

pith-pipeline@v1.1.0-grok45 · 6124 in / 2834 out tokens · 26894 ms · 2026-07-14T01:46:08.029937+00:00 · methodology

0 comments
read the original abstract

Accurate breast cancer risk prediction from screening mammography is critical for enabling personalized screening intervals and early detection. Recent deep learning methods have shown the value of longitudinal data and explicit temporal alignment. However, existing approaches either perform explicit alignment using a single mammographic view or model multiple views without explicit longitudinal alignment, limiting their ability to exploit the complementary spatial-temporal information used in clinical practice. To address this gap, we propose LMV-Net, a longitudinal multi-view breast cancer risk prediction model that jointly analyzes anatomically complementary CC and MLO views within an explicitly aligned longitudinal framework. We evaluate our approach on the public EMBED and CSAW-CC datasets, comparing it to state-of-the-art breast cancer risk prediction methods. Our model consistently outperforms existing approaches in overall risk prediction performance and across different breast density and cancer subgroups. Importantly, these improvements highlight the potential of longitudinal multi-view modeling to enhance risk stratification, paving the way for future work on personalized screening, earlier identification of high-risk patients, and more efficient screening resource allocation. The code is available at https://github.com/sot176/LMV-Net.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.